DIAB and 3A Composites Enter Licensing Agreement for PET Core Materials

11 May 2011

The agreement enables DIAB to utilize the 3A PET patent family relevant to Divinycell P manufacturing with unlimited restrictions for an indefinite future. DIAB CEO Anders Paulsson comments: ""We are pleased to get access to excellent PET technology that gives us continued ability to provide Divinycell P. For our customers this means no change, they can continue to buy our Divinycell P products to our certified data sheets.""

DIAB and 3A Composites have entered into a licensing agreement for manufacturing of PET core materials.

Share this story